Terms: = Bone cancer AND TIMP1, CLGI, EPA, EPO, HCI, TIMP, TIMP-1 AND Treatment
118 results:
1. miR-1293 suppresses osteosarcoma progression by modulating drug sensitivity in response to cisplatin treatment.
Wang T; Huang J; Chen G; Fu J; Li T; Zou X; Yi H
Int Immunopharmacol; 2024 Mar; 130():111702. PubMed ID: 38367464
[TBL] [Abstract] [Full Text] [Related]
2. Eicosapentaenoic acid enhances the sensitivity of osteosarcoma to cisplatin by inducing ferroptosis through the DNA-PKcs/AKT/NRF2 pathway and reducing PD-L1 expression to attenuate immune evasion.
Zhang Y; Shen G; Meng T; Lv Z; Li X; Li J; Li K
Int Immunopharmacol; 2023 Dec; 125(Pt B):111181. PubMed ID: 37951196
[TBL] [Abstract] [Full Text] [Related]
3. n-3 PUFAs Show Promise as Adjuvants in Chemotherapy, Enhancing their Efficacy while Safeguarding Hematopoiesis and Promoting bone Generation.
Gurav P; Garad S; Nirmala KR
Curr Top Med Chem; 2024; 24(1):45-59. PubMed ID: 37907485
[TBL] [Abstract] [Full Text] [Related]
4. Ectopic invasive ACTH-secreting pituitary adenoma mimicking chordoma: a case report and literature review.
Li Y; Zhu JG; Li QQ; Zhu XJ; Tian JH
BMC Neurol; 2023 Feb; 23(1):81. PubMed ID: 36814261
[TBL] [Abstract] [Full Text] [Related]
5. Myeloma Microenvironmental timp1 Induces the Invasive Phenotype in Fibroblasts to Modulate Disease Progression.
Ishihara R; Oda T; Murakami Y; Matsumura I; Watanabe S; Asao Y; Masuda Y; Gotoh N; Kasamatsu T; Takei H; Kobayashi N; Sasaki N; Saitoh T; Murakami H; Handa H
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768545
[TBL] [Abstract] [Full Text] [Related]
6. Efficacy and safety of erythropoietin in isolated spinal metastasis patients with total en bloc spondylectomy surgery: a case-control study.
Cao S; Lv K; Peng C; Bai G; Gao X; Wang J; Cao J; Ning R; Chu J; Liu T
Eur Spine J; 2023 Mar; 32(3):1021-1028. PubMed ID: 36715756
[TBL] [Abstract] [Full Text] [Related]
7. Addition of navitoclax to ongoing ruxolitinib treatment in patients with myelofibrosis (REFINE): a post-hoc analysis of molecular biomarkers in a phase 2 study.
Pemmaraju N; Garcia JS; Potluri J; Harb JG; Sun Y; Jung P; Qin QQ; Tantravahi SK; Verstovsek S; Harrison C
Lancet Haematol; 2022 Jun; 9(6):e434-e444. PubMed ID: 35576960
[TBL] [Abstract] [Full Text] [Related]
8. Prediction of Response to Erythropoiesis Stimulating Agents in Low-Risk Myelodysplastic Syndromes.
Hattakitpanitchakul S; Kobbuaklee S; Wudhikarn K; Polprasert C
Asian Pac J Cancer Prev; 2021 Dec; 22(12):4037-4042. PubMed ID: 34967586
[TBL] [Abstract] [Full Text] [Related]
9. Eosinophils in the pathogenesis of pancreatic disorders.
Manohar M; Kandikattu HK; Upparahalli Venkateshaiah S; Yadavalli CS; Mishra A
Semin Immunopathol; 2021 Jun; 43(3):411-422. PubMed ID: 33783592
[TBL] [Abstract] [Full Text] [Related]
10. Experimental Modeling of Eosinophil-Associated Diseases.
Upparahalli Venkateshaiah S; Manohar M; Kandikattu HK; Mishra A
Methods Mol Biol; 2021; 2241():275-291. PubMed ID: 33486743
[TBL] [Abstract] [Full Text] [Related]
11. Erythropoietin in bone homeostasis-Implications for efficacious anemia therapy.
Lappin KM; Mills KI; Lappin TR
Stem Cells Transl Med; 2021 Jun; 10(6):836-843. PubMed ID: 33475252
[TBL] [Abstract] [Full Text] [Related]
12. Inhibitory effect of cathepsin K inhibitor (ODN-MK-0822) on invasion, migration and adhesion of human breast cancer cells in vitro.
Vashum Y; Premsingh R; Kottaiswamy A; Soma M; Padmanaban A; Kalaiselvan P; Samuel S
Mol Biol Rep; 2021 Jan; 48(1):105-116. PubMed ID: 33294960
[TBL] [Abstract] [Full Text] [Related]
13. Ectopic GH-secreting pituitary adenoma of the clivus: systematic literature review of a challenging tumour.
Riccio L; Donofrio CA; Tomacelli G; De Blasi R; Melatini A
Pituitary; 2020 Aug; 23(4):457-466. PubMed ID: 32504302
[TBL] [Abstract] [Full Text] [Related]
14. Targeting on glycosylation of mutant FLT3 in acute myeloid leukemia.
Hu X; Chen F
Hematology; 2019 Dec; 24(1):651-660. PubMed ID: 31533545
[No Abstract] [Full Text] [Related]
15. Anti-proliferative effects of mesenchymal stem cells (MSCs) derived from multiple sources on ovarian cancer cell lines: an in-vitro experimental study.
Khalil C; Moussa M; Azar A; Tawk J; Habbouche J; Salameh R; Ibrahim A; Alaaeddine N
J Ovarian Res; 2019 Jul; 12(1):70. PubMed ID: 31351482
[TBL] [Abstract] [Full Text] [Related]
16. Cytokines secreted from bone marrow derived mesenchymal stem cells promote apoptosis and change cell cycle distribution of K562 cell line as clinical agent in cell transplantation.
Fathi E; Farahzadi R; Valipour B; Sanaat Z
PLoS One; 2019; 14(4):e0215678. PubMed ID: 31009502
[TBL] [Abstract] [Full Text] [Related]
17. Quercetin suppresses the proliferation and metastasis of metastatic osteosarcoma cells by inhibiting parathyroid hormone receptor 1.
Li S; Pei Y; Wang W; Liu F; Zheng K; Zhang X
Biomed Pharmacother; 2019 Jun; 114():108839. PubMed ID: 30978523
[TBL] [Abstract] [Full Text] [Related]
18. [Differential Diagnosis of Erythrocytosis - Background and Clinical Relevance].
Wille K; Sadjadian P; Griesshammer M
Dtsch Med Wochenschr; 2019 Jan; 144(2):128-135. PubMed ID: 30674061
[TBL] [Abstract] [Full Text] [Related]
19. The specific RIP1 inhibitor necrostatin-1 ameliorated degradation of ECM in human SW1353 cells.
Hu X; Zhu Y; Wang J; Tang J; Yu H; Xie Y; Dong Q
Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S1169-S1175. PubMed ID: 30604633
[TBL] [Abstract] [Full Text] [Related]
20. Rhu-epo down-regulates pro-tumorigenic activity of cancer-associated fibroblasts in multiple myeloma.
Desantis V; Frassanito MA; Tamma R; Saltarella I; Di Marzo L; Lamanuzzi A; Solimando AG; Ruggieri S; Annese T; Nico B; Vacca A; Ribatti D
Ann Hematol; 2018 Jul; 97(7):1251-1258. PubMed ID: 29589107
[TBL] [Abstract] [Full Text] [Related]
[Next]
